Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients

Autor: Martinelli, G. ^*, Iacobucci, I., Rosti, G., Pane, F., Amabile, M., Castagnetti, F., Cilloni, D., Soverini, S., Testoni, N., Specchia, G., Merante, S., Zaccaria, A., Frassoni, F., Saglio, G., Baccarani, M.

Publikováno v: In Annals of Oncology March 2006 17(3):495-502

Achieving a Major Molecular Response at the Time of a Complete Cytogenetic Response (CCgR) Predicts a Better Duration of CCgR in Imatinib-Treated Chronic Myeloid Leukemia Patients

Autor: Iacobucci, I, Saglio, Giuseppe, Rosti, G, Testoni, N, Pane, F, Amabile, M, Poerio, A, Soverini, S, Bassi, S, Cilloni, Daniela, Bassan, R, Breccia, M, Lauria, F, Izzo, B, Merante, S, Frassoni, F, Paolini, S, Montefusco, E, Baccarani, M, Martinelli, G, Gimema, Working, PARTY ON CHRONIC MYELOID LEUKEMIA

Publikováno v: Clinical cancer research
12 (2006): 3037–3042. doi:10.1158/1078-0432.CCR-05-2574
info:cnr-pdr/source/autori:Iacobucci I, Saglio G, Rosti, G, Testoni N, Pane F, Amabile M, Poerio A, Soverini S, Bassi S, Cilloni D, Bassan R, Breccia M, Lauria F, Izzo B, Marente S, Frassoni F, Paolini S, Montefusco E, Baccarini M, MArtinelli G, Ginema Working party/titolo:Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients/doi:10.1158%2F1078-0432.CCR-05-2574/rivista:Clinical cancer research (Print)/anno:2006/pagina_da:3037/pagina_a:3042/intervallo_pagine:3037–3042/volume:12

Purpose: Most patients with chronic-phase chronic myeloid leukemia (CML) who receive imatinib achieve a complete cytogenetic remission (CCgR) and low levels of BCR-ABL transcripts. CCgR is durable in the majority of patients but relapse occurs in a s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2233eb35f97bae24eb797cf717f606d
https://doi.org/10.1158/1078-0432.ccr-05-2574

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

THE ITALIAN MASTOCYTOSIS REGISTRY: THE FIRST FIVE YEARS

Autor: Merante, S., Neri, I., Magliacane, D., Fortina, A. Belloni, Ingeborg, F., Pastorello, E. A., Mauro, M., Minelli, R., Difonzo, E. D. Elisa, Guggiari, E., Peserico, A., Romani, I., Bocchia, M., Fontana, E., Di Nuzzo, S., Elli, E. M., Elena, C., Virginia Valeria Ferretti, Brazzelli, V., Ciccocioppo, R., Di Stefano, M., Bossi, G., Boveri, E., Virdi, A., Triggiani, M.

Publikováno v: Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::644cddf60a0f37c3f2a5550a95b45afa
http://hdl.handle.net/11577/3298190

International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.

Autor: Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria. Electronic address: wolfgang.r.sperr@meduniwien.ac.at., Kundi M; Institute of Environmental Health, Medical University of Vienna, Vienna, Austria., Alvarez-Twose I; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain., van Anrooij B; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; Department of Allergology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Oude Elberink JNG; Department of Allergology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Gorska A; Department of Allergology, Medical University of Gdańsk, Gdańsk, Poland., Niedoszytko M; Department of Allergology, Medical University of Gdańsk, Gdańsk, Poland., Gleixner KV; Department of Internal Medicine I, Division of Hematology and Hemostaseology, and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Hadzijusufovic E; Department of Internal Medicine I, Division of Hematology and Hemostaseology, and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria; Internal Medicine Small Animals, University Clinic for Small Animals, Department/University Clinic for Companion Animals and Horses, University of Veterinary Medicine, Vienna, Austria., Zanotti R; Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy., Bonadonna P; Allergy Unit, Verona University Hospital, Verona, Italy., Bonifacio M; Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy., Perkins C; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Illerhaus A; Department of Dermatology, University of Cologne, Cologne, Germany., Elena C; Department of Molecular Medicine and Department of Hematology Oncology, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Merante S; Department of Molecular Medicine and Department of Hematology Oncology, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Shoumariyeh K; Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., von Bubnoff N; Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Parente R; Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy., Jawhar M; III Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany., Belloni Fortina A; Pediatric Dermatology Unit, Department of Medicine, University of Padua, Padua, Italy., Caroppo F; Pediatric Dermatology Unit, Department of Medicine, University of Padua, Padua, Italy., Brockow K; Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, Munich, Germany., Zink A; Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, Munich, Germany., Fuchs D; University Clinic for Hematology and Internal Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria., Kilbertus AJ; Department of Dermatology and Venerology, Kepler University Hospital, Johannes Kepler University, Linz, Austria., Yavuz AS; Division of Hematology, Istanbul Medical School, University of Istanbul, Istanbul, Turkey., Doubek M; University Hospital and CEITEC Masaryk University, Brno, Czech Republic., Hägglund H; Division of Hematology, Department of Medical Sciences Uppsala University, Uppsala, Sweden., Panse J; Department of Oncology, Haematology, Haemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany., Sabato V; Faculty of Medicine and Health Sciences, Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium., Bretterklieber A; Department of Dermatology and Venereology, University Hospital Graz, Graz, Austria., Niederwieser D; University Hospital of Leipzig, Leipzig, Germany., Breynaert C; KU Leuven Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group and MASTeL, University Hospitals Leuven, Leuven, Belgium., Hartmann K; Department of Dermatology, University of Cologne, Cologne, Germany; Division of Allergy, Department of Dermatology, and Department of Biomedicine, University of Basel, Basel, Switzerland., Triggiani M; Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy., Nedoszytko B; Department of Dermatology, Medical University of Gdańsk, Gdańsk, Poland., Reiter A; III Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany., Orfao A; Centro de Investigación del Cáncer/IBMCC (USAL/CSIC), CIBERONC and IBSAL, Departamento de Medicina and Servicio General de Citometría, University of Salamanca, Salamanca, Spain., Hermine O; Imagine Institute Université Paris Descartes, Sorbonne, Paris Cité, Centre national de référence des mastocytoses, Paris, France., Gotlib J; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Arock M; Department of Hematological Biologie, Pitié-Salpêtrière Hospital, Paris Sorbonne University, Paris UMR8113, Ecole, France., Kluin-Nelemans HC; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2019 Dec; Vol. 6 (12), pp. e638-e649. Date of Electronic Publication: 2019 Oct 31.